Quick Takeaways
- ABBV - AbbVie Inc. has 34 insiders with reported activity on this page.
- Net insider value flow over the last year: -$21,791,006.
- Recent transaction rows are available for direct filing-level review.
- Info
- Significant Ownership
- Insider Ownership
- Insider Trading
- Financials
- Holders
Insider Transactions Reported by 34 Insiders of AbbVie Inc.
- Symbol
- ABBV on NYSE
- Location
- North Chicago, IL
What Changed
- Buy value: ; sell value: $21,791,006.
- Net share flow: -101,944.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Official SEC Source
Insider trading overview
Last 12 monthsNet insider flow leans to selling over the last 12 months. Net value: -$21,791,006.
Buys
$0
Shares: 0
Insiders: 0
Sells
$21,791,006
Shares: 101,944
Insiders: 4
Net
-$21,791,006
Shares: -101,944
Insiders: -4
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 46,279 | $0 | $10,744,698 | -$10,744,698 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 55,665 | $0 | $11,046,308 | -$11,046,308 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
AbbVie Inc. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Richard A. Gonzalez | Director | $87,456,513 | Mixed | 31 Mar 2025 | ||
| Robert A. Michael | CHAIRMAN OF THE BOARD AND CEO, Director | $49,272,918 | Mixed | 27 Feb 2026 | ||
| Azita Saleki-Gerhardt | Evp, Chief Operations Officer | $47,372,857 | -$8,407,055 | -15% | Mixed | 27 Feb 2026 |
| Laura J. Schumacher | Vice Chairman | $46,597,652 | Mixed | 25 Feb 2022 | ||
| Michael Severino | Vice Chairman | $29,817,686 | Mixed | 23 May 2022 | ||
| Thomas C. Freyman | Director | $23,114,946 | Mixed | 09 May 2025 | ||
| Thomas J. Hudson | Svp, Cso, Global Research | $21,933,260 | Mixed | 28 Feb 2024 | ||
| Jeffrey R. Stewart | Evp, Chief Commercial Officer | $19,601,046 | Mixed | 27 Feb 2026 | ||
| Nicholas J. Donoghoe | Evp, Chief Bus/Strat Officer | $19,465,074 | -$2,639,253 | -12% | Mixed | 27 Feb 2026 |
| Gosebruch Henry O | EVP, Chief Strategy Officer | $15,280,302 | Mixed | 16 May 2022 | ||
| Roopal Thakkar | EVP, R&D and CSO | $15,162,255 | Mixed | 27 Feb 2026 | ||
| Edward J. Rapp | Director | $14,323,680 | Mixed | 31 Mar 2026 | ||
| Scott T. Reents | Evp, Chief Financial Officer | $11,555,937 | Mixed | 27 Feb 2026 | ||
| Glenn F. Tilton | Director | $9,043,418 | Mixed | 09 May 2025 | ||
| Robert J. Alpern | Director | $8,553,154 | Mixed | 31 Mar 2026 | ||
| Elaine K. Sorg | Svp, Us Commercial Operations | $7,238,029 | Mixed | 25 Apr 2023 | ||
| Roxanne S. Austin | Director | $6,699,383 | Mixed | 09 May 2025 | ||
| Brian L. Durkin | Vp, Controller | $5,128,813 | Mixed | 28 Feb 2023 | ||
| Frederick H. Waddell | Director | $5,044,483 | Mixed | 09 May 2025 | ||
| William H.l. Burnside | Director | $4,696,083 | Mixed | 09 May 2025 | ||
| Edward M. Liddy | Director | $4,412,616 | Mixed | 31 Mar 2022 | ||
| Carrie C. Strom | Svp & Pres Global Allerg Aesth | $4,335,873 | Mixed | 11 May 2023 | ||
| Perry C. Siatis | Evp, Gc And Secretary | $3,899,142 | -$9,523,179 | -71% | Mixed | 27 Feb 2026 |
| Brett J. Hart | Director | $3,392,022 | Mixed | 09 May 2025 | ||
| Melody B. Meyer | Director | $2,873,951 | Mixed | 09 May 2025 | ||
| Rebecca B. Roberts | Director | $2,391,417 | Mixed | 09 May 2025 | ||
| David R. Purdue | SVP, Controller | $2,011,795 | -$1,221,519 | -38% | Mixed | 04 Mar 2026 |
| Kevin K. Buckbee | Svp, Controller | $1,894,481 | Mixed | 28 Feb 2025 | ||
| Demetris D. Crum | Evp, Chief Hr Officer | $1,766,879 | Mixed | 27 Feb 2026 | ||
| AbbVie Inc. | EVP, Chief HR Officer | $1,308,249 | Mixed | 01 Jul 2025 | ||
| Timothy J. Richmond | Evp, Chief Hr Officer | $1,295,392 | Filing P/S | 28 Feb 2025 | ||
| Thomas J. Falk | Director | $732,162 | Mixed | 09 May 2025 | ||
| Susan E. Quaggin | Director | $601,397 | Mixed | 31 Mar 2026 | ||
| Jennifer L. Davis | Director | $439,855 | Mixed | 09 May 2025 |
Top shareholders of AbbVie Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
10%
|
180,779,699
|
$41,306,353,424 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
|
Company |
8.6%
|
151,174,543
|
$34,541,871,411 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
4.6%
|
80,940,931
|
$18,494,193,324 | — | 31 Dec 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
3%
|
52,393,323
|
$11,971,351,030 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.5%
|
44,629,980
|
$10,179,098,610 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
2.3%
|
40,041,940
|
$9,149,183,466 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.5%
|
25,824,399
|
$5,900,616,785 | — | 31 Dec 2025 | |
| NORGES BANK |
13F
|
Company |
1.5%
|
25,668,761
|
$5,865,055,201 | — | 31 Dec 2025 | |
| Capital Research Global Investors |
13F
|
Company |
1.4%
|
25,408,200
|
$5,805,529,521 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1.4%
|
25,169,844
|
$5,751,060,095 | — | 31 Dec 2025 | |
| FMR LLC |
13F
|
Company |
1.3%
|
22,609,389
|
$5,166,019,290 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.2%
|
21,733,923
|
$4,965,984,066 | — | 31 Dec 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.84%
|
14,926,683
|
$3,410,597,797 | — | 31 Dec 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.84%
|
14,881,504
|
$3,400,274,102 | — | 31 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.76%
|
13,499,351
|
$3,084,466,589 | — | 31 Dec 2025 | |
| Capital World Investors |
13F
|
Company |
0.74%
|
13,071,444
|
$2,986,777,322 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.74%
|
12,995,625
|
$2,969,370,350 | — | 31 Dec 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.73%
|
12,924,311
|
$2,953,075,820 | — | 31 Dec 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.69%
|
12,133,331
|
$2,772,344,798 | — | 31 Dec 2025 | |
| Capital International Investors |
13F
|
Company |
0.66%
|
11,692,765
|
$2,671,982,867 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.6%
|
10,526,920
|
$2,405,295,950 | — | 31 Dec 2025 | |
| Amundi |
13F
|
Individual |
0.59%
|
10,450,406
|
$2,387,813,268 | — | 31 Dec 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.57%
|
10,129,714
|
$2,314,538,352 | — | 31 Dec 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.57%
|
10,060,638
|
$2,298,902,337 | — | 31 Dec 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.56%
|
9,826,388
|
$2,245,232,000 | — | 31 Dec 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.53%
|
9,397,734
|
$2,148,100,176 | — | 31 Dec 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.52%
|
9,147,766
|
$2,090,173,022 | — | 31 Dec 2025 | |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main |
13F
|
Company |
0.5%
|
8,919,066
|
$2,037,918,172 | — | 31 Dec 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.49%
|
8,608,026
|
$1,966,847,970 | — | 31 Dec 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.47%
|
8,279,502
|
$1,891,837,338 | — | 31 Dec 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.46%
|
8,107,480
|
$1,852,478,084 | — | 31 Dec 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.45%
|
7,889,869
|
$1,802,757,000 | — | 31 Dec 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.38%
|
6,709,941
|
$1,533,154,419 | — | 31 Dec 2025 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.37%
|
6,564,258
|
$1,499,867,312 | — | 31 Dec 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.36%
|
6,402,650
|
$1,462,863,500 | — | 31 Dec 2025 | |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO |
13F
|
Company |
0.33%
|
5,892,808
|
$1,346,447,700 | — | 31 Dec 2025 | |
| Swiss National Bank |
13F
|
Company |
0.27%
|
4,840,810
|
$1,106,076,677 | — | 31 Dec 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.27%
|
4,840,145
|
$1,105,924,732 | — | 31 Dec 2025 | |
| ENVESTNET ASSET MANAGEMENT INC |
13F
|
Company |
0.27%
|
4,828,226
|
$1,103,201,217 | — | 31 Dec 2025 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.24%
|
4,198,609
|
$959,340,170 | — | 31 Dec 2025 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.24%
|
4,160,516
|
$950,636,301 | — | 31 Dec 2025 | |
| NORDEA INVESTMENT MANAGEMENT AB |
13F
|
Company |
0.23%
|
4,149,959
|
$950,631,108 | — | 31 Dec 2025 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0.23%
|
4,142,939
|
$946,620,225 | — | 31 Dec 2025 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.23%
|
4,102,845
|
$937,459,054 | — | 31 Dec 2025 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.23%
|
4,064,980
|
$929,583,357 | — | 31 Dec 2025 | |
| National Pension Service |
13F
|
Company |
0.22%
|
3,856,731
|
$881,224,466 | — | 31 Dec 2025 | |
| LPL Financial LLC |
13F
|
Company |
0.22%
|
3,853,097
|
$880,393,997 | — | 31 Dec 2025 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.21%
|
3,798,212
|
$867,853,486 | — | 31 Dec 2025 | |
| Mitsubishi UFJ Asset Management Co., Ltd. |
13F
|
Company |
0.21%
|
3,752,683
|
$860,527,739 | — | 31 Dec 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.2%
|
3,495,917
|
$798,782,600 | — | 31 Dec 2025 |
Recent Insider Transactions by Companies or Individuals for AbbVie Inc.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Susan E. Quaggin | ABBV | Stock Equivalent Units | Award | 9.96% | 71 | 784 | 31 Mar 2026 | Direct | ||
| Edward J. Rapp | ABBV | Stock Equivalent Units | Award | 0.54% | 155 | 28,865 | 31 Mar 2026 | Direct | ||
| Robert J. Alpern | ABBV | Stock Equivalent Units | Award | 0.34% | 35 | 10,369 | 31 Mar 2026 | Direct | ||
| David R. Purdue | ABBV | Common Stock, $0.01 par value | Sale | -66.3% | $1,221,519 | $233.56 | -5,230 | 2,654 | 04 Mar 2026 | Direct |
| Perry C. Siatis | ABBV | Common Stock, $0.01 par value | Sale | -80.2% | $4,375,549 | $234.39 | -18,668 | 4,619 | 02 Mar 2026 | Direct |
| David R. Purdue | ABBV | Common Stock, $0.01 par value | Tax liability | -19.9% | -2,108 | 8,468 | 27 Feb 2026 | Direct | ||
| Demetris D. Crum | ABBV | Common Stock, $0.01 par value | Tax liability | -16.8% | -1,594 | 7,914 | 27 Feb 2026 | Direct | ||
| Roopal Thakkar | ABBV | Common Stock, $0.01 par value | Tax liability | -13.3% | -8,037 | 52,376 | 27 Feb 2026 | Direct | ||
| Robert A. Michael | ABBV | Common Stock, $0.01 par value | Tax liability | -17% | -36,523 | 178,737 | 27 Feb 2026 | Direct | ||
| Jeffrey R. Stewart | ABBV | Common Stock, $0.01 par value | Tax liability | -22.3% | -23,812 | 83,171 | 27 Feb 2026 | Direct | ||
| Perry C. Siatis | ABBV | Common Stock, $0.01 par value | Tax liability | -38.9% | -14,850 | 23,287 | 27 Feb 2026 | Direct | ||
| Scott T. Reents | ABBV | Common Stock, $0.01 par value | Tax liability | -35.8% | -21,638 | 38,777 | 27 Feb 2026 | Direct | ||
| Azita Saleki-Gerhardt | ABBV | Common Stock, $0.01 par value | Tax liability | -7.62% | -16,309 | 197,794 | 27 Feb 2026 | Direct | ||
| Nicholas J. Donoghoe | ABBV | Common Stock, $0.01 par value | Tax liability | -14.8% | -12,874 | 74,430 | 27 Feb 2026 | Direct | ||
| Perry C. Siatis | ABBV | Common Stock, $0.01 par value | Sale | -37% | $5,147,630 | $230.00 | -22,381 | 38,137 | 25 Feb 2026 | Direct |
| Perry C. Siatis | ABBV | Common Stock, $0.01 par value | Options Exercise | 58.7% | 22,381 | 60,518 | 25 Feb 2026 | Direct | ||
| Perry C. Siatis | ABBV | Option (Right to buy) | Options Exercise | -100% | -22,381 | 0 | 25 Feb 2026 | Direct | ||
| Roopal Thakkar | ABBV | Common Stock, $0.01 par value | Award | 42.9% | 18,137 | 60,413 | 18 Feb 2026 | Direct | ||
| Roopal Thakkar | ABBV | Option (Right to buy) | Award | 21,937 | 21,937 | 18 Feb 2026 | Direct | |||
| David R. Purdue | ABBV | Common Stock, $0.01 par value | Award | 134.8% | 6,071 | 10,576 | 18 Feb 2026 | Direct | ||
| David R. Purdue | ABBV | Option (Right to buy) | Award | 4,875 | 4,875 | 18 Feb 2026 | Direct | |||
| Jeffrey R. Stewart | ABBV | Common Stock, $0.01 par value | Award | 101% | 53,749 | 106,983 | 18 Feb 2026 | Direct | ||
| Jeffrey R. Stewart | ABBV | Option (Right to Buy) | Award | 26,812 | 26,812 | 18 Feb 2026 | Direct | |||
| Perry C. Siatis | ABBV | Common Stock, $0.01 par value | Award | 725.6% | 33,518 | 38,137 | 18 Feb 2026 | Direct | ||
| Perry C. Siatis | ABBV | Option (Right to buy) | Award | 19,500 | 19,500 | 18 Feb 2026 | Direct | |||
| Azita Saleki-Gerhardt | ABBV | Common Stock, $0.01 par value | Award | 20.8% | 36,811 | 214,103 | 18 Feb 2026 | Direct | ||
| Azita Saleki-Gerhardt | ABBV | Option (Right to Buy) | Award | 20,312 | 20,312 | 18 Feb 2026 | Direct | |||
| Demetris D. Crum | ABBV | Common Stock, $0.01 par value | Award | 34.9% | 2,460 | 9,508 | 18 Feb 2026 | Direct | ||
| Demetris D. Crum | ABBV | Option (Right to buy) | Award | 13,406 | 13,406 | 18 Feb 2026 | Direct | |||
| Nicholas J. Donoghoe | ABBV | Common Stock, $0.01 par value | Award | 49.9% | 29,057 | 87,304 | 18 Feb 2026 | Direct | ||
| Nicholas J. Donoghoe | ABBV | Option (Right to buy) | Award | 20,312 | 20,312 | 18 Feb 2026 | Direct | |||
| Scott T. Reents | ABBV | Common Stock, $0.01 par value | Award | 421.8% | 48,838 | 60,415 | 18 Feb 2026 | Direct | ||
| Scott T. Reents | ABBV | Option (Right to buy) | Award | 21,937 | 21,937 | 18 Feb 2026 | Direct | |||
| Robert A. Michael | ABBV | Common Stock, $0.01 par value | Award | 62.1% | 82,439 | 215,260 | 18 Feb 2026 | Direct | ||
| Robert A. Michael | ABBV | Option (Right to Buy) | Award | 81,251 | 81,251 | 18 Feb 2026 | Direct | |||
| Robert J. Alpern | ABBV | Stock Equivalent Units | Award | 0.33% | 34 | 10,257 | 31 Dec 2025 | Direct | ||
| Susan E. Quaggin | ABBV | Stock Equivalent Units | Award | 10.6% | 68 | 707 | 31 Dec 2025 | Direct | ||
| Edward J. Rapp | ABBV | Stock Equivalent Units | Award | 0.52% | 147 | 28,498 | 31 Dec 2025 | Direct | ||
| Susan E. Quaggin | ABBV | Stock Equivalent Units | Award | 11.8% | 67 | 634 | 30 Sep 2025 | Direct | ||
| Robert J. Alpern | ABBV | Stock Equivalent Units | Award | 0.33% | 33 | 10,151 | 30 Sep 2025 | Direct | ||
| Edward J. Rapp | ABBV | Stock Equivalent Units | Award | 0.52% | 145 | 28,152 | 30 Sep 2025 | Direct | ||
| Azita Saleki-Gerhardt | ABBV | Common Stock, $0.01 par value | Sale | -19.3% | $8,407,055 | $198.42 | -42,370 | 177,292 | 12 Aug 2025 | Direct |
| Azita Saleki-Gerhardt | ABBV | Common Stock, $0.01 par value | Options Exercise | 23.9% | 42,370 | 219,662 | 12 Aug 2025 | Direct | ||
| Azita Saleki-Gerhardt | ABBV | Option (Right to Buy) | Options Exercise | -100% | -42,370 | 0 | 12 Aug 2025 | Direct | ||
| Nicholas J. Donoghoe | ABBV | Common Stock, $0.01 par value | Sale | -18.6% | $2,639,253 | $198.51 | -13,295 | 58,247 | 05 Aug 2025 | Direct |
| Robert J. Alpern | ABBV | Stock Equivalent Units | Award | 0.4% | 40 | 10,038 | 30 Jun 2025 | Direct | ||
| Edward J. Rapp | ABBV | Stock Equivalent Units | Award | 0.64% | 177 | 27,785 | 30 Jun 2025 | Direct | ||
| Susan E. Quaggin | ABBV | Stock Equivalent Units | Award | 16.8% | 81 | 562 | 30 Jun 2025 | Direct | ||
| Thomas J. Falk | ABBV | Common Stock, $0.01 par value | Award | 1,203 | 1,203 | 09 May 2025 | Direct | |||
| Glenn F. Tilton | ABBV | Common Stock, $0.01 par value | Award | 2.39% | 1,203 | 51,564 | 09 May 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.